http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2463801-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3290992d9cdd84d706f92b5fcf971c3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C47-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C55-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C47-133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1278
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C13-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-608
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C13-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
filingDate 2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c590f5a3caa8601b99650db178990c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27417977d5bd68df482079166d7fa6bc
publicationDate 2010-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-2463801-A
titleOfInvention Liposomes comprising an isoprenoid lipid
abstract A liposome comprises an isoprenoid lipid and a pharmaceutically active component. The active is preferably an antigen and the isoprenoid, which may be obtained from hyperthermophilic Archaea, may have a formula (1):wherein Rw, Rx, Ryand Rz, are independently selected from an aliphatic or alicyclic group, or Rw and Rz and/or Ry and Rz are combined to form a di-ether group.
priorityDate 2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6132789-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008023264-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03092647-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415717922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426244186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20138397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25200834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450591146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414888040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20849290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783

Total number of triples: 55.